Peter C. Farrell - 14 Jun 2024 Form 4 Insider Report for Arcturus Therapeutics Holdings Inc. (ARCT)

Reporting relationship: Director
Issuer ticker: ARCT
Reported as of: 14 Jun 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 Jun 2024, 21:00:10 UTC
Prior SEC filing: 17 May 2024
Next SEC filing: 06 Sep 2024
Source filing: View source filing
Reporting owner signature: /s/ Ilan Katz, attorney-in-fact

Key filing fact

Peter C. Farrell filed Form 4 for Arcturus Therapeutics Holdings Inc. (ARCT) on 18 Jun 2024.

Key facts

This page summarizes Peter C. Farrell's Form 4 filing for Arcturus Therapeutics Holdings Inc. (ARCT).
3 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 18 Jun 2024, 21:00.

Change

Previous filing in this sequence was filed on 17 May 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ARCT transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +3,131
Change %: +6%
Price: $0.000000
Shares after: 55,741
Date: 14 Jun 2024
Ownership: Direct
Footnotes: F1

ARCT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 42,955
Date: 14 Jun 2024
Ownership: Peter C. Farrell Trust.

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ARCT transaction Derivative

Deferred Stock Units

Options Exercise

Transaction value: $0
Shares: -3,131
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 14 Jun 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,131
Exercise price: $0.000000
Footnotes: F1, F2

ARCT transaction Derivative

Stock option (right to buy)

Award

Transaction value: $0
Shares: +15,000
Change %
Price: $0.000000
Shares after: 15,000
Date: 14 Jun 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,000
Exercise price: $31.00
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024.

Footnote F2

Represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer.

Footnote F3

Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2024 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer.